Christina Anne Austin-Tse, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucokinase | 1 | 2020 | 99 | 0.670 |
Why?
|
Cilia | 5 | 2021 | 498 | 0.630 |
Why?
|
Rare Diseases | 4 | 2024 | 631 | 0.590 |
Why?
|
Usher Syndromes | 1 | 2018 | 56 | 0.580 |
Why?
|
Kartagener Syndrome | 2 | 2013 | 33 | 0.540 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 2055 | 0.440 |
Why?
|
Extracellular Matrix Proteins | 1 | 2018 | 835 | 0.440 |
Why?
|
Ciliary Motility Disorders | 1 | 2013 | 51 | 0.430 |
Why?
|
Long QT Syndrome | 3 | 2022 | 472 | 0.430 |
Why?
|
Hyperglycemia | 1 | 2020 | 1389 | 0.370 |
Why?
|
Zebrafish Proteins | 3 | 2021 | 1019 | 0.370 |
Why?
|
Zebrafish | 6 | 2021 | 3037 | 0.330 |
Why?
|
Genetic Variation | 8 | 2024 | 6611 | 0.320 |
Why?
|
Genomics | 7 | 2022 | 5928 | 0.280 |
Why?
|
Actinin | 2 | 2024 | 165 | 0.270 |
Why?
|
Glycoproteins | 1 | 2013 | 2202 | 0.250 |
Why?
|
Databases, Genetic | 2 | 2022 | 1758 | 0.230 |
Why?
|
Genetic Testing | 6 | 2024 | 3591 | 0.230 |
Why?
|
Frameshift Mutation | 1 | 2024 | 393 | 0.200 |
Why?
|
Dyneins | 2 | 2013 | 126 | 0.200 |
Why?
|
Genome, Human | 4 | 2024 | 4456 | 0.200 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 54 | 0.190 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2024 | 706 | 0.190 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5892 | 0.190 |
Why?
|
Endophenotypes | 1 | 2022 | 258 | 0.180 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2021 | 199 | 0.170 |
Why?
|
Anemia, Aplastic | 1 | 2022 | 231 | 0.170 |
Why?
|
Phenotype | 8 | 2024 | 16731 | 0.170 |
Why?
|
Muscular Diseases | 1 | 2024 | 553 | 0.160 |
Why?
|
Exercise Tolerance | 1 | 2024 | 846 | 0.160 |
Why?
|
Chromosome Breakpoints | 1 | 2018 | 93 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
Heterozygote | 2 | 2022 | 2798 | 0.150 |
Why?
|
Pedigree | 3 | 2022 | 4545 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 12253 | 0.130 |
Why?
|
Cytoskeletal Proteins | 1 | 2021 | 1328 | 0.130 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2017 | 163 | 0.130 |
Why?
|
Introns | 1 | 2018 | 969 | 0.120 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4124 | 0.110 |
Why?
|
Chlamydomonas | 1 | 2013 | 10 | 0.110 |
Why?
|
Carboxypeptidases | 1 | 2014 | 121 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1240 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 2001 | 0.110 |
Why?
|
Sequence Analysis, DNA | 3 | 2024 | 4785 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 1568 | 0.110 |
Why?
|
Planarians | 1 | 2013 | 56 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1094 | 0.100 |
Why?
|
Fetus | 1 | 2020 | 1882 | 0.100 |
Why?
|
Metformin | 1 | 2020 | 909 | 0.100 |
Why?
|
Mutation | 7 | 2024 | 30266 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2021 | 1335 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2024 | 2057 | 0.090 |
Why?
|
Electrocardiography | 2 | 2022 | 6413 | 0.090 |
Why?
|
Disease | 1 | 2016 | 673 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1665 | 0.090 |
Why?
|
Tubulin | 1 | 2014 | 695 | 0.090 |
Why?
|
Open Reading Frames | 1 | 2013 | 818 | 0.090 |
Why?
|
Diabetes, Gestational | 1 | 2020 | 1263 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3450 | 0.080 |
Why?
|
Embryo, Nonmammalian | 1 | 2013 | 910 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 954 | 0.080 |
Why?
|
Mitochondria | 1 | 2022 | 3682 | 0.080 |
Why?
|
Glutamic Acid | 1 | 2014 | 1191 | 0.080 |
Why?
|
Humans | 26 | 2024 | 768970 | 0.070 |
Why?
|
Chromosome Mapping | 3 | 2023 | 4625 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 3110 | 0.070 |
Why?
|
Insulin | 1 | 2020 | 6610 | 0.060 |
Why?
|
Distal Myopathies | 1 | 2024 | 18 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 13021 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3671 | 0.060 |
Why?
|
Mutation, Missense | 2 | 2024 | 2592 | 0.060 |
Why?
|
Software | 2 | 2022 | 4479 | 0.060 |
Why?
|
Proteome | 1 | 2013 | 1891 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12801 | 0.050 |
Why?
|
Electronic Health Records | 2 | 2017 | 4879 | 0.050 |
Why?
|
Adult | 9 | 2024 | 223851 | 0.050 |
Why?
|
Mitochondrial ADP, ATP Translocases | 1 | 2022 | 11 | 0.050 |
Why?
|
Female | 12 | 2024 | 397515 | 0.050 |
Why?
|
Acetonitriles | 1 | 2022 | 55 | 0.050 |
Why?
|
Pregnancy | 2 | 2023 | 30265 | 0.050 |
Why?
|
Genetic Association Studies | 2 | 2024 | 2748 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3612 | 0.050 |
Why?
|
STAT1 Transcription Factor | 1 | 2022 | 343 | 0.040 |
Why?
|
Animals | 7 | 2024 | 169335 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18068 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2024 | 606 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 917 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1298 | 0.040 |
Why?
|
Dystonia | 1 | 2022 | 378 | 0.040 |
Why?
|
Mitochondrial Diseases | 1 | 2022 | 344 | 0.040 |
Why?
|
Gene Frequency | 2 | 2016 | 3626 | 0.040 |
Why?
|
Male | 10 | 2024 | 365203 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 620 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1074 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1794 | 0.030 |
Why?
|
Pyrroles | 1 | 2022 | 1125 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2023 | 1771 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41808 | 0.030 |
Why?
|
Developmental Disabilities | 1 | 2023 | 1520 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2022 | 1423 | 0.030 |
Why?
|
Larva | 1 | 2014 | 514 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 609 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4148 | 0.020 |
Why?
|
Computational Biology | 1 | 2024 | 3562 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5404 | 0.020 |
Why?
|
Drug Design | 1 | 2016 | 1046 | 0.020 |
Why?
|
Pyrazoles | 1 | 2022 | 2029 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2012 | 752 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2911 | 0.020 |
Why?
|
Child | 3 | 2024 | 80960 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3112 | 0.020 |
Why?
|
Pyrimidines | 1 | 2022 | 3048 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
Chromosomes | 1 | 2012 | 578 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4978 | 0.020 |
Why?
|
Markov Chains | 1 | 2012 | 979 | 0.020 |
Why?
|
Microtubules | 1 | 2014 | 1062 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3914 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4651 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2012 | 1526 | 0.020 |
Why?
|
Homozygote | 1 | 2012 | 1780 | 0.020 |
Why?
|
Epilepsy | 1 | 2022 | 3326 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 1966 | 0.020 |
Why?
|
Lipids | 1 | 2016 | 3345 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8094 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2830 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 16053 | 0.020 |
Why?
|
Adolescent | 2 | 2024 | 89244 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13048 | 0.010 |
Why?
|
Middle Aged | 3 | 2024 | 223737 | 0.010 |
Why?
|
Mice | 2 | 2024 | 82072 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 6901 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15879 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60131 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 54962 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22379 | 0.010 |
Why?
|
United States | 1 | 2021 | 73186 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 81903 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40261 | 0.010 |
Why?
|